Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Vacuna del papil·lomavirus"'
Autor:
Francesc Bosch, Laia Bruni, Jin-Kyoung Oh, Hyunju Lee, Crystal Freeman, Young-Tak Kim, Laia Alemany, Beatriz Serrano, Shin-Wha Lee, Jae Kwan Lee
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Papillomavirus Research
Papillomavirus Research, Vol 7, Iss, Pp 26-42 (2019)
Universidad de Barcelona
Papillomavirus Research
Papillomavirus Research, Vol 7, Iss, Pp 26-42 (2019)
Background We aimed to review the burden and the potential impact of human papillomavirus (HPV) vaccines on HPV-related diseases in the Republic of Korea and to discuss cervical cancer prevention practices in this country. Methods Cancer burden stati
Autor:
Pino Saladrigues, Marta del
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Universidad de Barcelona
El virus del papiloma humano (VPH) es un virus cuya familia está constituida por más de 100 tipos. De ellos, hay al menos 14 que se consideran agentes causales de diversos tipos de cáncer que afectan tanto a hombres como a mujeres.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ef09f599e86f13ee06336abb5504a79c
http://hdl.handle.net/2445/180577
http://hdl.handle.net/2445/180577
Autor:
Maria Kyrgiou, Freddie Bray, Ann Van den Bruel, Mario Poljak, Daniel Kelly, Pekka Nieminen, Christine Bergeron, Maggie Cruickshank, Dietmar Schmidt, David A. Ritchie, Murat Gultekin, Marc Arbyn, Laia Bruni, Philippe Morice, Philip Poortmans, Elisabete Weiderpass, Partha Basu
Publikováno v:
International Journal of Cancer
Dipòsit Digital de la UB
Universidad de Barcelona
International journal of cancer, 148(2):277-284
Dipòsit Digital de la UB
Universidad de Barcelona
International journal of cancer, 148(2):277-284
The age‐standardised incidence of cervical cancer in Europe varies widely by country (between 3 and 25/100000 women‐years) in 2018. Human papillomavirus (HPV) vaccine coverage is low in countries with the highest incidence and screening performan
Autor:
Mamadou S Diallo, Oya Zeren Afsar, Marcela Contreras, Roberta Pastore, D. Scott LaMontagne, Martha Velandia-González, Laia Alemany, Laia Bruni, Maria Brotons, Anna Saura-Lázaro, Alexandra Montoliu, Marta Gacic-Dobo, Paul Bloem, Liudmila Mosina
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Preventive Medicine
Universidad de Barcelona
Preventive Medicine
WHO/UNICEF estimates for HPV vaccination coverage from 2010 to 2019 are analyzed against the backdrop of the 90% coverage target for HPV vaccination by 2030 set in the recently approved global strategy for cervical cancer elimination as a public heal
Autor:
Anna-Barbara Moscicki, S. de Sanjose, Joel M. Palefsky, R. Sankaranarayanan, Margaret Stanley, Andreas M. Kaufmann, Julia M.L. Brotherton, Suzanne M. Garland, Neerja Bhatla
Publikováno v:
Papillomavirus Research
Papillomavirus Research, Vol 4, Iss, Pp 35-38 (2017)
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Papillomavirus Research, Vol 4, Iss, Pp 35-38 (2017)
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona
It is well-established that immunocompromised people are at increased risk of HPV-related disease compared with those who are immunocompetent. Prophylactic HPV sub-unit vaccines are safe and immunogenic in immunocompromised people and it is strongly
Autor:
Aureli Torné, Marta del Pino, Lorena Marimon, Ines Torras, Carla Henere, Cristina Vidal Martí, Jaume Ordi, Adela Saco, Meritxell Munmany
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Vaccines
Vaccines, Vol 8, Iss 245, p 245 (2020)
Volume 8
Issue 2
Universidad de Barcelona
Vaccines
Vaccines, Vol 8, Iss 245, p 245 (2020)
Volume 8
Issue 2
Background: Recent studies have shown preliminary evidence that vaccination against human papillomavirus (HPV) could decrease the risk of persistent/recurrent HSIL in women treated for high-grade cervical intraepithelial lesion (HSIL). We aimed to de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d43fb425fbcd541313b73f5ed6a9e32
http://hdl.handle.net/2445/174062
http://hdl.handle.net/2445/174062
Autor:
Carmen Cabezas, Jordi Casabona, F. Xavier Bosch, Silvia de Sanjosé, Maria Brotons, Laia Bruni, Laura Monfil, Talita Duarte-Salles, Esther Roura, L. Urbiztondo
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Universidad de Barcelona
Extensive multiple-age cohort human papillomavirus (HPV) vaccination has proved to be highly effective. We aimed to determine the 8-year population impact of a female single-age cohort HPV vaccination programme on the incidence of anogenital warts (A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aeab5fef250b82e1f7cb278e6c8493e6
http://hdl.handle.net/2445/174590
http://hdl.handle.net/2445/174590
Autor:
Mimar Ramis-Salas
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Universidad de Barcelona
Democratic access to scientific evidence contributes to the freedom of individuals to make informed decisions regarding scientific findings that affect their lives. In the case of the human papilloma virus (HPV), which causes cervical cancer, a debat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e44d7b40e9d6d732388a8672f243ae87
http://hdl.handle.net/2445/178026
http://hdl.handle.net/2445/178026
Autor:
Sharon J.B. Hanley, Joanne Yarwood, Pierre Van Damme, Marc Arbyn, Mira Kojouharova, Nubia Muñoz, Emilie Karafillakis, Alex Vorsters, Paolo Bonanni, F. Xavier Bosch, Marc Baay, Noel T. Brewer, Jade Pattyn, Ross L. Cameron, Helena C. Maltezou, Eduardo L. Franco
Publikováno v:
Papillomavirus Research, Vol 8, Iss, Pp-(2019)
Dipòsit Digital de la UB
Universidad de Barcelona
Papillomavirus Res
Papillomavirus Research
Dipòsit Digital de la UB
Universidad de Barcelona
Papillomavirus Res
Papillomavirus Research
The Human Papillomavirus (HPV) Prevention and Control Board convened a meeting in Bucharest, Romania (May 2018), to discuss the role of healthcare providers (HCPs) in prevention programs, with a focus on HPV vaccination and cervical cancer screening.
Autor:
Martínez Gómez, Xavier, Curran, Adrian, Campins Martí, Magda, Alemany, Laia, Rodrigo-Pendás, J. Á., Borruel, Natalia, Castellsagué, Xavier, Díaz de Heredia, Cristina, Moraga-Llop, F. A., del Pino, M., Torné, A., Universitat Autònoma de Barcelona
Publikováno v:
Scientia
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Dipòsit Digital de la UB
Universidad de Barcelona
Eurosurveillance
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Dipòsit Digital de la UB
Universidad de Barcelona
Eurosurveillance
High-risk populations; Human papillomavirus infection; Vaccines Poblacions d'alt risc; Virus del papil·loma humà; Vacunes Poblaciones de alto riesgo; Virus del papiloma humano; Vacunas INTRODUCTION: Although human papillomavirus (HPV) routine vacci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a629a2a2beed349d2652feda6d8f2961
https://hdl.handle.net/11351/3882
https://hdl.handle.net/11351/3882